antipsychotics
TRANSCRIPT
Chetan RastogiM.Pharm 1st Year Pharmacology
1
Psychosis Psychosis refers to a variety of mental disorders
characterized by one or more of the following
symptoms:
diminished and distorted capacity to process
information and draw logical conclusions.
hallucinations, delusions, marked loosening of
associations.
disorganized behavior, and aggression or
violence.2
Psychosis:
Psychosis can be broadlyCategorized in to 2 groups:1 ORGANIC2 FUNCTIONAL
Psychosis
3
1.Acute and chronic organic brain syndromes (cognitive disorders) such as, Delirium and dementia, prominent features of confusion, disorientation, defective memory and disorganized behavior.
2.Functional disorders such as, memory and orientation mostly retained by emotion, thought, reasoning and behavior are altered.
3.Schizophrenia (split mind) i.e. splitting of perception and interpretation from reality- hallucination, inability to think coherently. Schizophrenia is often described in terms of positive or negative (deficit) symptoms..
4.Paranoid state i.e. fixed delusions (false beliefs) and loss of insight in to abnormality.
4
Schizophrenia
It is a thought disorder.The disorder is characterized by a
divorcement from reality in the mind of the person (psychosis).
It may involved visual and auditory hallucinations, delusions, intense suspicion, feelings of persecution or control by external forces (paranoia), depersonalization, and there is attachment of excessive personal significance to daily events, called “ideas of reference”.
5
Schizophrenia
Positive Symptoms
Hallucinations, delusions, paranoia, ideas of reference.
Negative Symptoms
Apathy, social withdrawal, anhedonia, emotional
blunting, Poor speech –Cognitive impairment Poor speech –Cognitive impairment ,
extreme inattentiveness or lack of motivation to
interact with the environment.
These symptoms are progressive and non-responsive to
medication.6
Psychosis Producing Drugs
1) Levodopa
2) CNS stimulants
a) Cocaine
b) Amphetamines
c) Khat, cathinone, methcathinone
3) Apomorphine
4) Phencyclidine
7
Dopamine Theory of Schizophrenia
Dopamine Correlates:• Antipsychotics reduce dopamine synaptic activity.• These drugs produce Parkinson-like symptoms.• Drugs that increase DA in the limbic system cause
psychosis.• Drugs that reduce DA in the limbic system
(postsynaptic D2 antagonists) reduce psychosis.• Increased DA receptor density (Post-mortem, PET).• Changes in amount of homovanillic acid (HVA), a
DA metabolite, in plasma, urine, and CSF.
8
Dopamine Theory of Schizophrenia
Evidence against the hypothesisAntipsychotics are only partially effective in
most (70%) and ineffective for some patients.Phencyclidine, an NMDA receptor antagonist,
produces more schizophrenia-like symptoms in non-schizophrenic subjects than DA agonists.
Atypical antipsychotics have low affinity for D2 receptors.
Focus is broader now and research is geared to produce drugs with less extrapyramidal effects.
9
Dopamine System
There are four major pathways for the dopaminergic system in the brain:
I. The Nigro-Stiatal Pathway.II. The Mesolimbic Pathway.III. The Mesocortical Pathway.IV. The Tuberoinfundibular Pathway.
10
11
Catecholamines
Tyrosine Tyrosine hydroxylase
L-Dopa Dopa decarboxylase
Dopamine (DA) Dopamine
hydroxylase
Norepinephrine (NE)(Noradrenaline)
Phenylethanolamine-
-N-methyltransferase
Epinephrine (EPI)(Adrenaline)
12
Dopamine Synapse
DA
L-DOPA
Tyrosine
Dopamine SystemDOPAMINE RECEPTORS
There are at least five subtypes of receptors: Receptor
D1D2D3D4D5
14
15
Dopamine System DOPAMINE RECEPTORS
Receptor 2o Messenger System D1 cAMP D2 cAMP,K+
ch.,Ca2+ch. D3 cAMP,K+
ch.,Ca2+ch. D4 cAMP D5 cAMP
16
Dopamine Reuptake System
17
ANTIPSYCHOTICS
Antipsychotic drugs are alsoknown as Neuroleptics, Ataractic,Major Tranquilizer and Anti-Schizophrenic drugs. A firstgeneration of antipsychotics,known as Typical antipsychotics,was discovered in the 1950s. Mostof the drugs in the secondgeneration, known as Atypical
antipsychotics,have been developed more recently.
18
CLASSIFICATION
A.Typical Antipsychotics: (traditional/older)traditional/older)
1. Phenothiazines:
a. Aliphatic side chain: Chlorpromazine, Triflupromazine
b. Piperidine side chain: Thioridazine
c. Piperazine side chain: Trifluoperazine, perphenazine
Fluphenazine
2. Butyrophenones: Haloperidol, Trifluperidol, Penfluridol,
droperidol, domperidone
19
3. Thioxanthenes: Flupenthixol
4. Other heterocyclics: Pimozide, Loxapine,
molindone, sulpiride, amisulpiride, penfluridol, Remoxipride, metoclopramide
B. Atypical/newer antipsychotics: Clozapine, Risperidone, Olanzapine, Quetiapine, Aripiprazole, Ziprasidone,
paloparidone
20
Low potencyLow potency High potencyHigh potency NEWERNEWER
ChlorpromaziChlorpromazinene
ThioridazineThioridazine
ThiothixeneThiothixene
ExtrapyramidExtrapyramidal symptoms al symptoms LESSLESS
Anti-ch MOREAnti-ch MORE
Haloperidol, Haloperidol, Fluphenazine,TrFluphenazine,Trifluoperazine,Peifluoperazine,Perphennazine, rphennazine, PimozidePimozide
Extrapyramidal-Extrapyramidal-MORE,MORE,
AntiCh LESSAntiCh LESS
ClozapineClozapine
OlanzapineOlanzapine
QuetiapineQuetiapine
AripiprazoleAripiprazole
RisperidoneRisperidone
ZiprasidoneZiprasidone
21
Traditional Vs. AtypicalTraditional Vs. Atypical Mainly DAMainly DAMainly D2Mainly D2Treat mostly Treat mostly
POSITIVE symptomsPOSITIVE symptomsMore adverse effectsMore adverse effectsLess useful in Less useful in
refractory diseaserefractory disease
DA and 5HTDA and 5HTD2+D4+5HTD2+D4+5HTTreat POSITIVE and Treat POSITIVE and
NEGATIVENEGATIVE symptomssymptoms
Lesser adverse Lesser adverse effectseffects
Useful in refractory Useful in refractory diseasedisease
22
Mechanism of Action:
-Antipsychotic blocks D₂receptors in the brain'sDopaminergic pathway.
-Some also block or partiallyblock serotonin receptors(particularly 5HT2A, C and
5HT1A receptors)
-But antipsychotic drugs can
alsoblock wide range of receptortargets.
24
In the Mesolimbic- Mesocortical and Nigrostriatal pathway Antipsychotic blocks:
25
In the Tuberoinfundibular pathway Antipsychotics block:
Dopamine released at this site regulates the secretion of prolactinfrom anterior the pituitary gland.Antipsychotics blocks D₂ receptor at this site.
26
Antipsychotic blocks D₂ receptors Some also block or partially block serotonin receptors
27
Pharmacology of Antipsychotics:Typical Antipsychotics
Phenothiazine
Absorption
Concentration
Metabolism
Vd Dose
Chlorpromazine (CPZ)
More consistent effect in IV and IM administration
Highly bound to plasma and tissue protein
Metabolized in liver by CYP2D6 enzyme
Large 20 L/kg
Acute single dose lasts 6-8 hours t⅟₂ is 18-30 hrs
Triflupromazine
More potent than CPZ
-- -- --
Thioridazine Low potency with anticholinergic action
-- -- --
Trifluoperazine, Fluphenazine
High potency with Autonomic action
-- -- -- Depot IM inj every 2-4 weeks (25mg/ml )
28
Butyrophenones Potency t⅟₂ Dose
Haloperidol Potent antipsychotic Produces few autonomic effects
24 hours. --
Trifluperidol Similar toHaloperidol but slightly more potent
-- --
Penfluridol Exceptional long acting neuroleptic, used for chronic Schizophrenia, affective withdrawl and social mal-adjustment
-- 20-60 mg , once weekly
29
Thioxanthenes
Flupenthixol Less sedative than CPZ, indicated for Schizophrenia and other Psychoses.
Other heterocyclics
t⅟₂
Pimozide Specific DA antagonist with little adrenergic or cholinergic blocking activity. Used in Gilles de la Tourett’s syndrome and ticks. Long Duration of action.
48-60 hrs. (after single dose)
30
Atypical Antisychotic drugs
These are newer 2nd
Generation antipsychoticsthat have weak D₂
receptorblocking but potent 5-HT₂antagonistic activity. TheyMay improve the impairedCognitive function inpsychotics.
31
Atypical Blocking activity Metabolism(Enzyme)
t⅟₂ and Dose
Clozapine A very potent antipsychotic
D₂, D₄, 5HT₂, α receptors
By CYP3A4 t⅟₂ - 12 hours
Risperidone
-- Combination of D₂+5HT₂ , High affinity for α₁, α₂ and H₁ receptors
-- Dose - Low dose <6 mg/day
Olanzapine Potent antipsychotic Broader spectrum of efficacy
Monoaminergic (D₂, 5HT₂, α₁, α₂) as well as muscarinic and H₁ receptors
By CYP1A2 and Glucuronyl transferase
t⅟₂ - 24-30 hours
Quetiapine New short- acting antipsychotic
5HT₁А, 5HT₂, D₂, α₁, α₂ and H₁ receptor
By CYP3A4 --
Aripiprazole
Unique antipsychotic which is partial agonist at D₂ and 5HT₁А
5HT₂ By CYP2D6 and CYP3A4
t⅟₂ - 3days
Ziprasidone
Latest antipsychotic , moderately potent inhibitor.
Combination D₂+5HT₂A/₂C +H₁ + α₁,Na reuptake
-- t⅟₂ - 8 hours
32
ADVERSE EFFECTS OF TYPICAL NEUROLEPTICSAnticholinergic (antimuscarinic) side
effects:Dry mouth, blurred vision, tachycardia,
constipation, urinary retention, impotence
33
ADVERSE EFFECTS OF TYPICAL NEUROLEPTICSAntiadrenergic (Alpha-1) side effects:
Orthostatic hypotension w/ reflex tachycardia
sedation
34
ADVERSE EFFECTS OF TYPICAL NEUROLEPTICSAntihistamine effect: sedation, weight gain
35
KEY CONCEPT: DOPAMINE-2 RECEPTOR BLOCKADE IN THE BASAL GANGLIA RESULTS IN EXTRAPYRAMIDAL MOTOR SIDE EFFECTS (EPS).
DYSTONIANEUROLEPTIC MALIGNANT SYNDROMEPARKINSONISMTARDIVE DYSKINESIAAKATHISIA
36
ADVERSE EFFECTS OF TYPICAL NEUROLEPTICS (Continued)Increased prolactin secretion (common with all;
from dopamine blockade)Weight gain (common, antihistamine effect?)Photosensitivity (v. common w/ phenothiazines)Lowered seizure threshold (common with all)Leucopenia , agranulocytosis (rare; w/
phenothiazines)Retinal pigmentopathy (rare; w/ phenothiazines)
37
ADVERSE EFFECTS OF TYPICAL NEUROLEPTICS (Continued)
Chlorpromazine and thioridazine produce marked autonomic side effects and sedation; EPS tend to be weak (thioridazine) or moderate (chlorpromazine).
Haloperidol, thiothixene and fluphenazine produce weak autonomic and sedative effects, but EPS are marked.
38
MANAGEMENT OF EPSDystonia and parkinsonism: anticholinergic
antiparkinson drugs
Neuroleptic malignant syndrome: muscle relaxants, DA agonists, supportive
Akathisia: benzodiazepines, propranolol
Tardive dyskinesia: increase neuroleptic dose; switch to clozapine
39
40